YF-H-2015005, a CXCR4 Antagonist, for the Mobilization of Hematopoietic Stem Cells in Non-Hodgkin Lymphoma Patients: A Randomized, Controlled, Phase 3 Clinical Trial

Background: YF-H-2015005, a novel CXCR4 antagonist, has been proven to increase the quantities of circulating hematopoietic stem cells (HSCs), which results in an adequate collection of HSCs in non-Hodgkin lymphoma (NHL) patients. Methods: This was a multicenter, double-blind, randomized (1:1), plac...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Weiping, Li, Yufu, Wang, Quanshun, Su, Hang, Ding, Kaiyang, Shuang, Yuerong, Gao, Sujun, Zou, Dehui, Jing, Hongmei, Chai, Ye, Zhang, Yicheng, Liu, Lihong, Wang, Chunling, Liu, Hui, Lin, Jinying, Zhu, Haiyan, Yao, Chen, Yan, Xiaoyan, Shang, Meixia, Wang, Shufang, Chang, Fengyuan, Wang, Xiaopei, Zhu, Jun, Song, Yuqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884449/
https://www.ncbi.nlm.nih.gov/pubmed/33604348
http://dx.doi.org/10.3389/fmed.2021.609116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884449/
https://www.ncbi.nlm.nih.gov/pubmed/33604348
http://dx.doi.org/10.3389/fmed.2021.609116

Ejemplares similares